UC San Diego, Department of Radiation Medicine and Applied Sciences, La Jolla, CA
Deborah Catherine Marshall , Madeleine E. Jackson , Jona Ashok Hattangadi
Background: The Open Payments program discloses industry payments to identified physicians (‘physician payments’). We characterize these payments by oncology specialty. Methods: We analyzed the December 2014 release of Open Payments data on physician payments made from August-December 2013. We characterized physician payments by type (general or research). We also evaluate physician ownership interests in reporting manufacturers. Data were aggregated by physician and oncology specialty [medical oncology (hematology/oncology, medical oncology, pediatric hematology/oncology); radiation oncology; and surgical oncology (surgical oncology, gynecologic oncology)]. We compared the number of physicians receiving payments to the total number of active physicians in each specialty in 2012 (AMA. Physician Characteristics and Distribution in the US. Chicago: AMA; 2014). Results: There were 82,213 payments to 9,893 oncology physicians (50% vs. 46% for all medical specialties) totaling $31 million (‘M’), Table. Payments for food/beverage were most common (79%) but represent only 10% of the total value. The most common nature of payment by total value was compensation for services (excluding consulting and CME) in medical oncology (38%), consulting fees in radiation oncology (30%), and education in surgical oncology (27%). Ownership interests totaled $8M in amount invested and $12M in total value of interest. Medical oncology had the highest proportion of physicians with ownership interest (1.7%) of oncology specialties. Conclusions: These data can inform policy-making and advocacy efforts for oncology specialties. Partially supported by the NIH (Grant TL1TR00098).
Specialty | Number of payments | % of physicians receiving payments | Total value: all payments | Total value: general payments | % | Total value: research payments | % |
---|---|---|---|---|---|---|---|
Medical oncology | 74,107 | 54% | $26,317,128 | $14,900,718 | 57% | $11,416,410 | 43% |
Radiation oncology | 4,612 | 31% | $3,440,178 | $1,048,742 | 30% | $2,391,436 | 70% |
Surgical oncology | 3,494 | 86% | $1,108,222 | $1,082,796 | 98% | $25,426 | 2% |
All oncology | 82,213 | 50% | $30,865,528 | $17,032,256 | 55% | $13,833,272 | 45% |
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Abstract Disclosures
2019 ASCO Annual Meeting
First Author: Mudit Chowdhary
2022 ASCO Annual Meeting
First Author: Imraan Jan
2021 ASCO Annual Meeting
First Author: Emilie Garcia
2024 ASCO Gastrointestinal Cancers Symposium
First Author: Victor Lo